文献速递其他结缔组织病

癌症相关肌炎的遗传影响

Genetic Influences in Cancer-Associated Myositis.
PubMed 文献 · Arthritis Rheumatol · 2022-12-20

本文综述特发性炎症性肌病(IIM)五种临床亚型中癌症风险分布不均,皮肌炎患者风险尤高;癌症风险在IIM诊断前后约3年达峰,病后10年仍升高。文章提出IIM可能是癌症的结果而非原因(副肿瘤现象),并综述支持遗传因素参与癌症相关肌炎(CAM)的证据。

要点

  • IIM分皮肌炎、多发性肌炎、包涵体肌炎、抗合成酶综合征和免疫介导坏死性肌病五种亚型,癌症风险分布不均,皮肌炎最高。
  • 癌症风险在IIM诊断前后约3年达峰,病后10年仍升高;肺癌、结直肠癌、卵巢癌多在IIM起病前出现,黑色素瘤、宫颈癌、口咽癌和非黑色素瘤皮肤癌多在诊断后发生。
  • 鉴于IIM诊断与恶性肿瘤出现时间接近,有假说认为IIM可能是癌症的结果而非原因(副肿瘤现象),由此区分出癌症相关肌炎(CAM)。

核心结论

  • IIM与癌症的关系已被广泛认识,但CAM的病理生理机制仍不明确。
  • 遗传因素在IIM发生中起作用,剖析IIM与癌症共享的分子机制可为自身免疫在癌症发生和进展中的作用提供线索。

研究设计与样本

  • 本文为综述,讨论支持遗传因素参与癌症相关肌炎(CAM)的证据。

主要发现

  • IIM五种临床亚型中癌症风险分布不均,皮肌炎患者风险尤高。
  • 癌症风险在IIM诊断前后约3年达峰,病后10年仍升高。
  • 肺癌、结直肠癌和卵巢癌通常在IIM起病前出现,而黑色素瘤、宫颈癌、口咽癌和非黑色素瘤皮肤癌通常在IIM诊断后发生。

关键数值与推荐

  • IIM区分为皮肌炎、多发性肌炎、包涵体肌炎、抗合成酶综合征和免疫介导坏死性肌病五种临床亚型。
  • 癌症风险在IIM诊断前后约3年达峰,病后10年仍升高。
  • 肺癌、结直肠癌、卵巢癌多在IIM起病前出现;黑色素瘤、宫颈癌、口咽癌、非黑色素瘤皮肤癌多在IIM诊断后发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Idiopathic inflammatory myopathies (IIMs) comprise a heterogeneous group of rare immune-mediated disorders that primarily affect muscles but also lead to dysfunction in other organs. Five different clinical subphenotypes of IIM have been distinguished: dermatomyositis, polymyositis, inclusion body myositis, antisynthetase syndrome, and immune-mediated necrotizing myopathy. Excess mortality and morbidity associated with IIM are largely attributed to comorbidities, particularly cancer. The risk of malignancy is not equally distributed among IIM groups and is particularly high among patients with dermatomyositis. The cancer risk peaks around 3 years on either side of the IIM diagnosis and remains elevated even 10 years after the onset of the disease. Lung, colorectal, and ovarian neoplasms typically arise before the onset of IIM, whereas melanoma, cervical, oropharyngeal, and nonmelanoma skin cancers usually develop after IIM diagnosis. Given the close temporal proximity between IIM diagnosis and the emergence of malignancy, it has been proposed that IIM could be a consequence rather than a cause of cancer, a process known as a paramalignant phenomenon. Thus, a separate group of IIMs related to paramalignant phenomenon has been distinguished, known as cancer-associated myositis (CAM). Although the relationship between IIM and cancer is widely recognized, the pathophysiology of CAM remains elusive. Given that genetic factors play a role in the development of IIM, dissection of the molecular mechanisms shared between IIM and cancer presents an opportunity to examine the role of autoimmunity in cancer development and progression. In this review, the evidence supporting the contribution of genetics to CAM will be discussed.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Patasova K, Lundberg IE, Holmqvist M, et al. Genetic Influences in Cancer-Associated Myositis. Arthritis Rheumatol. 2022. PMID: 36053262. doi:10.1002/art.42345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。